User profiles for D Vena
Daniel VenaHarvard Medical School, Brigham and Women's Hospital Verified email at bwh.harvard.edu Cited by 998 |
Neurotoxicity of purine analogs: a review.
BD Cheson, DA Vena, FM Foss… - Journal of Clinical …, 1994 - ascopubs.org
PURPOSE The purine analogs, fludarabine, cladribine, and pentostatin, are active against
a broad spectrum of indolent lymphoid malignancies. They also have similar toxicities, …
a broad spectrum of indolent lymphoid malignancies. They also have similar toxicities, …
[HTML][HTML] gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma
…, SA Rosenberg, P Choyke, D Vena… - … England Journal of …, 2011 - Mass Medical Soc
Background Stimulating an immune response against cancer with the use of vaccines remains
a challenge. We hypothesized that combining a melanoma vaccine with interleukin-2, an …
a challenge. We hypothesized that combining a melanoma vaccine with interleukin-2, an …
[HTML][HTML] Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer
…, A Arons, JC Pugliese, D Vena… - New England journal …, 2022 - Mass Medical Soc
Background The incidence of anal cancer is substantially higher among persons living with
the human immunodeficiency virus (HIV) than in the general population. Similar to cervical …
the human immunodeficiency virus (HIV) than in the general population. Similar to cervical …
Measuring response in solid tumors: unidimensional versus bidimensional measurement
…, M Christian, M Terenziani, D Vena… - Journal of the …, 1999 - academic.oup.com
BACKGROUND: Tumor shrinkage is a common end point used in screening new cytotoxic
agents. The standard World Health Organization criterion for partial response is a 50% or …
agents. The standard World Health Organization criterion for partial response is a 50% or …
Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins
…, VJ Land, J Miser, J Shuster, D Vena - Journal of Clinical …, 1999 - ascopubs.org
PURPOSE: The incidence of secondary leukemia after epipodophyllotoxin treatment and
the relationship between epipodophyllotoxin cumulative dose and risk are not well …
the relationship between epipodophyllotoxin cumulative dose and risk are not well …
Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.
EL Trimble, JD Adams, D Vena, MJ Hawkins… - Journal of clinical …, 1993 - ascopubs.org
PURPOSE To provide an investigational drug, paclitaxel, now commercially available, to
women with refractory ovarian cancer and to evaluate response and toxicity in these patients. …
women with refractory ovarian cancer and to evaluate response and toxicity in these patients. …
Gait analysis in orthopedic foot and ankle surgery—topical review, part 1: principles and uses of gait analysis
Gait analysis, the systematic study of human walking, is a field that has been studied for well
over 100 years. With the technological and scientific advancements of the last several …
over 100 years. With the technological and scientific advancements of the last several …
Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN
…, FA Curro, P Hujoel, AH Sung, D Vena… - Journal of dental …, 2011 - journals.sagepub.com
Case reports and cohort studies have linked bisphosphonate therapy and osteonecrosis of
the jaws (ONJ), but neither causality nor specific risks for lesion development have been …
the jaws (ONJ), but neither causality nor specific risks for lesion development have been …
The sleep apnea–specific pulse-rate response predicts cardiovascular morbidity and mortality
Rationale: Randomized controlled trials have been unable to detect a cardiovascular benefit
of continuous positive airway pressure in unselected patients with obstructive sleep apnea (…
of continuous positive airway pressure in unselected patients with obstructive sleep apnea (…
Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias
BD Cheson, DA Vena, J Barrett… - Journal of Clinical …, 1999 - ascopubs.org
PURPOSE: The nucleoside analogs fludarabine, 2′-deoxycoformycin (DCF), and 2-chlorodeoxyadenosine
(CdA), commonly used in the treatment of patients with indolent lymphoid …
(CdA), commonly used in the treatment of patients with indolent lymphoid …